Different Limb Lengths in Gastric Bypass Surgery (SLIM) - Part 3: Metabolism and Inflammation

NCT05471037 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2026-04-29

No results posted yet for this study

Summary

Investigation of underlying metabolic mechanisms and impact on the two surgical procedures on inflammatory factors.

Conditions

  • Obesity, Morbid

Interventions

PROCEDURE

Long Biliopancreatic Limb LRYGB

LRYGB with an 180 cm biliopancreatic limb (BPL) and an alimentary limb (AL) of 80 cm.

PROCEDURE

Short Biliopancreatic Limb LRYGB

Standard LRYGB with a 80 cm BPL and a 180 cm long AL.

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Anne Christin Meyer-Gerspach, PD Dr. phil. II Dr. habil. · St. Clara Forschung AG / St. Claraspital AG

  • Bettina Wölnerhanssen, PD Dr. med. · St. Clara Forschung AG / St. Claraspital AG

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2026-10-01
Completion
2026-10-01

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05471037 on ClinicalTrials.gov